PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#Quad Pharms ×

UPDATED
Regulatorische Updates
8. Sept. 2026•1 Min. Lesezeit
Quad Pharms Isoniazid Injection (100 mg/mL) Listed as Discontinued in FDA ANDA089816
FDA records show Quad Pharms' Isoniazid injectable (100 mg/mL) under ANDA089816 is marked as discontinued.
1
UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Discontinues Methotrexate Sodium Injection (ANDA089309)
The FDA has listed Quad Pharms' methotrexate sodium injection (product 001) as discontinued under ANDA089309.